MML Investors Services
ATRS

MML Investors Services’s Antares Pharma, Inc. ATRS Stock Holding History

MML Investors Services’s Portfolio ATRS Stock Details ATRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-40,100
Closed -$109K – 1638
2018
Q4 		$109K Sell
40,100
-500
-1% -$1.65K ﹤0.01% 1453
2018
Q3 		$136K Buy
40,600
+19,500
+92% +$60.2K ﹤0.01% 1555
2018
Q2 		$54K Sell
21,100
-7,000
-25% -$17.4K ﹤0.01% 1339
2018
Q1 		$62K Sell
28,100
-2,800
-9% -$6.3K ﹤0.01% 1346
2017
Q4 		$61K Sell
30,900
-11,500
-27% -$25K ﹤0.01% 1373
2017
Q3 		$137K Sell
42,400
-747
-2% -$2.31K ﹤0.01% 1268
2017
Q2 		$139K Buy
43,147
+30,000
+228% +$85K ﹤0.01% 1226
2017
Q1 		$37K Buy
+13,147
New +$31.6K ﹤0.01% 802

Other funds holding ATRS

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JAM
JW Asset Management Miami Beach, Florida $244M AUM 71.51% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

MML Investors Services's ATRS Position: Q1 2019 in Review

MML Investors Services sold out of Antares Pharma, Inc. (ATRS) in Q1 2019, closing a stake of 40,100 shares — an estimated $109K sold.

MML Investors Services first reported a position in ATRS in Q1 2017 and held it in 8 quarters. The position peaked at $139K in Q2 2017. 132 funds tracked by Wall St. Rank hold ATRS as of Q1 2019.

  • MML Investors Services reported no remaining Antares Pharma, Inc. position as of Q1 2019 after selling out during the quarter.
  • MML Investors Services sold 40,100 Antares Pharma, Inc. shares in Q1 2019, an estimated $109K.
  • MML Investors Services first reported a position in Antares Pharma, Inc. in Q1 2017 and held it in 8 quarters.
  • MML Investors Services's Antares Pharma, Inc. position peaked at $139K in Q2 2017.
  • 132 funds tracked by Wall St. Rank held Antares Pharma, Inc. as of Q1 2019.

Based on MML Investors Services's 13F filing for Q1 2019, filed 10 May 2019.